Try our Advanced Search for more refined results
UroGen Pharma Ltd.
-
Order | Filed: April 11, 2024 | Entered: April 11, 2024 UroGen Pharma Ltd. et al v. Teva Pharmaceuticals, Inc. et al
Patent - Abbreviated New Drug Application(ANDA) | Delaware
Order
STANDING ORDER REGARDING BRIEFING IN ALL CASES (nmf)
-
Utility | Filed: April 10, 2024 | Entered: April 10, 2024 UroGen Pharma Ltd. et al v. Teva Pharmaceuticals, Inc. et al
Patent - Abbreviated New Drug Application(ANDA) | Delaware
Case Assigned/Reassigned
Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb)
-
Misc | Filed: April 02, 2024 | Entered: April 03, 2024 UroGen Pharma Ltd. et al v. Teva Pharmaceuticals, Inc. et al
Patent - Abbreviated New Drug Application(ANDA) | Delaware
Disclosure Statement - Rule 7.1
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent UroGen Pharma Ltd. for UroGen Pharma Inc. (mrr)
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Archive of over 450,000 articles
- Database of over 2.1 million cases
- 62,000+ organization-specific pages.
- Daily and real-time news and case alerts on organizations, industries, and customized search queries.
- Significant legal events involving law firms, companies, industries, and government agencies.
- Learn more
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login